Bosdou J, Venetis C, Anagnostis P, Savvaidou D, Chatzimeletiou K, Zepiridis L
Int J Mol Sci. 2025; 26(4).
PMID: 40004120
PMC: 11855118.
DOI: 10.3390/ijms26041656.
Crespi B, Bushell A, Dinsdale N
Biol Rev Camb Philos Soc. 2024; 100(2):871-891.
PMID: 39542451
PMC: 11885704.
DOI: 10.1111/brv.13166.
Taieb A, Asma G, Jabeur M, Fatma B, Nassim B, Asma B
Clin Med Insights Endocrinol Diabetes. 2024; 17:11795514241296777.
PMID: 39494232
PMC: 11528641.
DOI: 10.1177/11795514241296777.
Guan C, Zhang D, Sun X, Ma X, Xia H
Stem Cells Int. 2024; 2024:3100942.
PMID: 39108701
PMC: 11303045.
DOI: 10.1155/2024/3100942.
Sage M, Duffy D
Endocrinology. 2024; 165(7).
PMID: 38889246
PMC: 11212825.
DOI: 10.1210/endocr/bqae071.
Acetate ameliorates ovarian mitochondrial dysfunction in letrozole-induced polycystic ovarian syndrome rat model by improving mitofusin-2.
Olaniyi K, Areloegbe S
J Physiol Sci. 2024; 74(1):22.
PMID: 38561673
PMC: 10983676.
DOI: 10.1186/s12576-024-00908-5.
FOXL2 interaction with different binding partners regulates the dynamics of ovarian development.
Migale R, Neumann M, Mitter R, Rafiee M, Wood S, Olsen J
Sci Adv. 2024; 10(12):eadl0788.
PMID: 38517962
PMC: 10959415.
DOI: 10.1126/sciadv.adl0788.
Local effect of allopregnanolone in rat ovarian steroidogenesis, follicular and corpora lutea development.
Caceres A, Cardone D, Sanhueza M, Bosch I, Cuello-Carrion F, Rodriguez G
Sci Rep. 2024; 14(1):6402.
PMID: 38493224
PMC: 10944484.
DOI: 10.1038/s41598-024-57102-1.
Subtle perturbations of ovarian steroidogenesis in patients classified as Poseidon Group 3. Which consequences for therapeutic strategy?.
Hugues J
Front Endocrinol (Lausanne). 2024; 15:1231585.
PMID: 38384970
PMC: 10879926.
DOI: 10.3389/fendo.2024.1231585.
Impact of a hypocaloric dietary intervention on antral follicle dynamics in eumenorrheic women with obesity.
Oldfield A, Carter F, Reeves R, Jarrett B, Vanden Brink H, Lujan M
Hum Reprod. 2024; 39(4):801-811.
PMID: 38335228
PMC: 10988108.
DOI: 10.1093/humrep/deae017.
Effect of BMI on cumulative live birth rates in patients that completed IVF treatment: a retrospective cohort study of 16,126 patients.
Zheng Z, Zhang X, Wu F, Liao H, Zhao H, Zhang M
Endocr Connect. 2024; 13(3).
PMID: 38197872
PMC: 10895320.
DOI: 10.1530/EC-23-0105.
Lupeol attenuated the NAFLD and PCOS-induced metabolic, oxidative, hormonal, histopathological, and molecular injuries in mice.
Malekinejad H, Zeynali-Moghaddam S, Rezaei-Golmisheh A, Alenabi A, Malekinejad F, Alizadeh A
Res Pharm Sci. 2023; 18(5):551-565.
PMID: 37842512
PMC: 10568958.
DOI: 10.4103/1735-5362.383710.
Letrozole use in vitrified single-blastocyst transfer cycles is associated with lower risk of large for gestational age infants in patients with polycystic ovary syndrome.
Zhang Y, Fu X, Gao S, Gao S, Gao S, Ma J
J Assist Reprod Genet. 2023; 40(12):2885-2894.
PMID: 37815736
PMC: 10656372.
DOI: 10.1007/s10815-023-02956-z.
Neuropeptide Y directly reduced apoptosis of granulosa cells, and the expression of NPY and its receptors in PCOS subjects.
Urata Y, Salehi R, Wyse B, Jahangiri S, Librach C, Tzeng C
J Ovarian Res. 2023; 16(1):182.
PMID: 37653540
PMC: 10469470.
DOI: 10.1186/s13048-023-01261-8.
Paxillin knockout in mouse granulosa cells increases fecundity†.
Vann K, Weidner A, Walczyk A, Astapova O
Biol Reprod. 2023; 109(5):669-683.
PMID: 37552051
PMC: 10651069.
DOI: 10.1093/biolre/ioad093.
Metabolic Mechanisms and Potential Therapeutic Targets for Prevention of Ovarian Aging: Data from Up-to-Date Experimental Studies.
Valtetsiotis K, Valsamakis G, Charmandari E, Vlahos N
Int J Mol Sci. 2023; 24(12).
PMID: 37372976
PMC: 10298538.
DOI: 10.3390/ijms24129828.
Immune Dysfunction in Polycystic Ovary Syndrome.
Banerjee S, Cooney L, Stanic A
Immunohorizons. 2023; 7(5):323-332.
PMID: 37195871
PMC: 10579973.
DOI: 10.4049/immunohorizons.2200033.
Androgen signalling in the ovaries and endometrium.
Lissaman A, Girling J, Cree L, Campbell R, Ponnampalam A
Mol Hum Reprod. 2023; 29(6).
PMID: 37171897
PMC: 10663053.
DOI: 10.1093/molehr/gaad017.
The Relationship Between Insulin Resistance and Obesity and Serum Anti-Mullerian Hormone Level in Chinese Women with Polycystic Ovary Syndrome: A Retrospective, Single-Center Cohort Study.
Zhao H, Zhou D, Liu C, Zhang L
Int J Womens Health. 2023; 15:151-166.
PMID: 36778752
PMC: 9911904.
DOI: 10.2147/IJWH.S393594.
A Narrative Review Discussing the Efficiency of Personalized Dosing Algorithm of Follitropin Delta for Ovarian Stimulation and the Reproductive and Clinical Outcomes.
Doroftei B, Ilie O, Anton N, Marcu O, Scripcariu I, Ilea C
Diagnostics (Basel). 2023; 13(2).
PMID: 36672987
PMC: 9858569.
DOI: 10.3390/diagnostics13020177.